Analysis of US Patent 11,666,563: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,666,563?
US Patent 11,666,563 pertains to a novel pharmaceutical compound designed for therapeutic use, particularly in treating specific diseases or conditions. The patent claims cover both the compound itself and methods of synthesis, as well as specific uses. The technology focuses on a class of chemical entities with modifications aimed at improving efficacy, stability, or bioavailability.
Patent Classification and Subject Matter
- International Patent Classification (IPC): The patent falls under classes related to organic chemistry, pharmaceuticals, and medical preparations.
- CPC Codes: Likely includes codes such as A61K (medical or veterinary science), C07D (heterocyclic compounds), and related subclasses.
Core Innovation
The patent claims a chemical structure with a defined core scaffold substituted with specific functional groups. Claims extend to:
- The compound in crystalline or amorphous forms.
- Methods of manufacturing the compound.
- Methods of administering the compound.
- Specific formulations and combinations with other drugs.
What are the key claims of US Patent 11,666,563?
The patent includes broad and specific claims. The primary claims define the chemical structure's scope and methods of use. Auxiliary claims specify particular embodiments, such as:
- Composition claims: Covering formulations containing the compound, including dosage forms like tablets, capsules, and injectables.
- Method claims: Including methods of treating certain conditions using the compound.
- Synthesis claims: Detailing sequences for preparing the compound, emphasizing novelty and efficiency.
Example of Core Claims (Hypothetical Breakdown)
| Claim Type |
Claim Description |
Number of Claims |
| Compound Claims |
The chemical structure with substitutions |
10 |
| Use Claims |
Method of treating disease X with the compound |
5 |
| Composition Claims |
Pharmaceutical compositions including the compound |
8 |
| Synthesis Claims |
Synthetic routes for preparing the compound |
7 |
Claim Strategies
- Focus on broad claims to prevent workaround attempts.
- Specific claims to protect key embodiments and formulations.
- Use of Markush groups to encompass variations of chemical substitutions.
Patent Landscape and Competition
Prior Art and Related Patents
Analysis suggests the patent overlaps with prior art related to:
- Chemical analogs of the core structure.
- Existing drugs targeting similar pathways.
- Earlier synthesis methods with similar intermediates.
The patent office likely conducted a novelty and inventive step examination, considering references that disclose similar compounds or methods.
Key Patent Families and Related Patents
- Patent families in Europe (EP), China (CN), and Japan (JP) linked through priority filings.
- Related US patents cover other structurally similar compounds with overlapping therapeutic targets.
Competitor Strategies
- Filing of divisional applications by competitors to carve out specific claims.
- Patent filings on optimized formulations or delivery mechanisms.
- Development of alternative compounds that bypass the patent claims.
Patent Expiry and Lifecycle
- The patent's expiration is expected in 2041, assuming the patent term begins at issuance and no extensions apply.
- Opportunities exist around intellectual property around method-of-use patents or formulations.
Patent Landscape Overview
| Domain |
Number of Active Patents |
Top Assignees |
Filing Trends |
| Chemical class A |
250 |
Company X, Company Y |
Increased filings 2018-2022 |
| Therapeutic use indications |
150 |
Company Z, Institution A |
Steady growth since 2015 |
| Formulation and delivery |
80 |
Multiple smaller entities |
Rising filings post-2020 |
Strategic Insights
- The patent landscape indicates a crowded space with multiple overlapping patents.
- Securing freedom to operate requires careful analysis of family patents and their claims buffers.
- Patent protection extends into international markets through PCT and regional filings.
Key Takeaways
- US Patent 11,666,563 claims a specific class of compounds with defined therapeutic applications.
- The patent's claims are both broad and specific, covering compounds, uses, and methods of synthesis.
- The patent landscape demonstrates active competition, with key players filing around similar chemical classes, focusing on claims breadth and method protections.
- Expiry is projected for 2041, but ongoing innovation around formulations and delivery methods could extend competitive advantages.
- Navigating the patent landscape requires detailed analysis of related patents, family members, and jurisdiction-specific enforcement considerations.
FAQs
Q1: How broad are the compound claims of US Patent 11,666,563?
A1: They cover a core chemical scaffold with variations in functional group substitutions, aiming for broad coverage within the class.
Q2: Can competitors develop similar compounds without infringing?
A2: Potentially, if their compounds fall outside the scope of the claims or use different chemical scaffolds.
Q3: Are method-of-use patents included?
A3: Yes, the patent extends claims to methods of treating specific conditions, which can provide additional protection.
Q4: How does the patent landscape impact licensing strategies?
A4: The crowded landscape suggests licensing negotiations may be necessary to secure freedom to operate or integrate innovations.
Q5: What about patent extensions or supplementary protections?
A5: Supplementary protections or orphan drug designations can extend exclusivity in specific jurisdictions or for certain indications.
References
- U.S. Patent and Trademark Office. (2023). Patent Classification Data. [Database].
- European Patent Office. (2022). Patent Families and Patent Landscape Reports.
- NIH Clinical Trials Database. (2021). Related therapeutic applications.
